華通醫藥(002758.SZ):向浙農控股集團等發行股份購買資產獲證監會核准
格隆匯 6 月 30日丨華通醫藥(002758.SZ)公佈,公司於2020年6月30日收到中國證券監督管理委員會(“中國證監會”)出具的《關於核准浙江華通醫藥股份有限公司向浙農控股集團有限公司等發行股份購買資產的批覆》(證監許可[2020]1241號)。批覆內容如下:
核准公司向浙農控股集團有限公司發行101,714,094股股份、向浙江泰安泰投資諮詢合夥企業(有限合夥)發行63,482,171股股份、向浙江省興合集團有限責任公司發行55,567,177股股份、向浙江興合創業投資有限公司發行7,365,921股股份、向汪路平發行11,179,644股股份、向李盛樑發行9,791,773股股份、向趙劍平發行4,059,271股股份、向王自強發行3,893,282股股份、向陳志浩發行3,511,463股股份、向方建華髮行3,049,539股股份、向王春喜發行2,212,770股股份、向葉鬱亭發行2,023,581股股份、向邵玉英發行1,948,814股股份、向林昌斌發行1,877,670股股份、向袁炳榮發行1,816,605股股份、向戴紅聯發行968,292股股份、向馬羣發行885,489股股份、向蔡永正發行885,285股股份、向羅堯根發行832,317股股份、向呂亮發行770,717股股份購買相關資產。
批覆自下發之日起12個月內有效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.